The drug eribulin, currently approved for the third-line treatment of breast cancer, may represent a new treatment option for pediatric patients with a type of cancer called sarcoma, according to results of preclinical studies ...
Nov 5, 2013
For children with central nervous system cancers, the presence of a specific genetic modification—hypermethylation of the TERT promoter—may help predict tumor progression and patient survival, according to results presented ...
Nov 5, 2013
A mouse model predicted that inhibition of the enzyme MEK using targeted therapy may provide an effective, single-agent treatment for pediatric patients with neurofibroma, and early results from a phase I trial support this ...
Nov 5, 2013
A genomewide association study (GWAS) has revealed two specific variations in the NFIB gene that may identify which children and adolescents with osteosarcoma have metastatic disease or are at high risk for metastasis, according ...
Nov 5, 2013
A comprehensive genomic profiling test using next-generation sequencing has identified genomic alterations in more than half of pediatric cancer samples tested that would give clinicians potential targets on which to base ...
Nov 5, 2013
(Medical Xpress)—In the first randomized trial of the effects of cell phone use, University of Kansas and Notre Dame researchers found that when parenting coaches texted and called mothers who had participated in a home-based ...
Nov 5, 2013
There's good news and there's bad news. Which do you want to hear first?
Nov 5, 2013
(Medical Xpress)—Oxford University researchers have conducted the first academic study into the hidden problem of adolescent to parent violence in the UK.
Nov 5, 2013
